Hyperion DeFi, Inc. (HYPD)
NASDAQ: HYPD · Real-Time Price · USD
3.580
+0.280 (8.48%)
At close: Sep 8, 2026, 4:00 PM EDT
3.570
-0.010 (-0.28%)
After-hours: Sep 8, 2026, 4:38 PM EDT
Hyperion DeFi Employees
Hyperion DeFi had 9 employees as of December 31, 2025. The number of employees decreased by 5 or -35.71% compared to the previous year.
Employees
9
Change (1Y)
-5
Growth (1Y)
-35.71%
Revenue / Employee
$155,633
Profits / Employee
-$1,983,150
Market Cap
55.63M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 9 | -5 | -35.71% | 9 | 0 |
| Dec 31, 2024 | 14 | -43 | -75.44% | 13 | 1 |
| Dec 31, 2023 | 57 | 16 | 39.02% | 57 | 0 |
| Dec 31, 2022 | 41 | -4 | -8.89% | 41 | 0 |
| Dec 31, 2021 | 45 | 11 | 32.35% | 43 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Celularity | 115 |
| Xilio Therapeutics | 76 |
| Seres Therapeutics | 66 |
| aTyr Pharma | 60 |
| Veru Inc. | 20 |
| Tevogen | 18 |
| ImageneBio | 18 |
| Instil Bio | 17 |
HYPD News
- 4 hours ago - Hyperion DeFi price target raised to $8.45 from $7.30 at Chardan - TheFly
- 8 hours ago - Hyperion DeFi launches new $20M share buyback program - TheFly
- 8 hours ago - Hyperion DeFi Raises Guidance and Announces $20M Share Repurchase Program - GlobeNewsWire
- 22 days ago - Hyperion DeFi price target raised to $7.10 from $6.60 at Cantor Fitzgerald - TheFly
- 26 days ago - Hyperion DeFi Earnings Call Transcript: Q2 2026 - Transcripts
- 26 days ago - Hyperion DeFi Slides: Q2 2026 - Filings
- 26 days ago - Hyperion DeFi Earnings release: Q2 2026 - Filings
- 26 days ago - Hyperion DeFi Quarterly report: Q2 2026 - Filings